Buy Novocure Stock | NVCR Stock Price & Latest News | Public.com
NVCR

Novocure

$0.00 (0.00%)Today
    View Novocure (NVCR) stock trends here

    About NVCR

    NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.09
    0.06
    0.03
    0
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    $0.01

    Actual EPS
    Q1 2021

    Stats

    Market Cap$13,23B
    Volume861,29k
    Price-to-Earnings Ratio711.11
    Dividend Rate
    Dividend Yield
    1 Year High$194.75
    1 Year Low$53.40
    Open$131.53
    High$133.74
    Low$117.58

    Buy any stock with any amount of money.

    Download the App
    Download the app